Harvard Bioscience (HBIO) Interest & Investment Income (2019 - 2026)
Harvard Bioscience (HBIO) reported Interest & Investment Income of -$1.7 million for Q1 2026, down 85.21% year-over-year from -$11.7 million in Q1 2025, and up 26.72% on a QoQ basis from -$2.4 million in Q4 2025.
Harvard Bioscience (HBIO) has 8 years of Interest & Investment Income data on file, last reported at -$1.7 million in Q1 2026.
- Quarterly Interest & Investment Income fell 85.21% year-over-year to -$1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.8 million (down 57.15% YoY) and the FY2025 annual result came in at -$4.9 million, down 39.06% from the prior year.
- Interest & Investment Income improved to -$1.7 million in Q1 2026 per HBIO's latest filing, from -$2.4 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at -$384000.0 in Q1 2022 and bottomed at -$2.4 million in Q4 2025.
- The 5-year median for Interest & Investment Income is -$882000.0 (2023), against an average of -$967705.9.
- The widest annual swing landed in 2023, when Interest & Investment Income sank 153.65%; it then advanced 22.9% in 2024.
- Tracing HBIO's Interest & Investment Income over 5 years: stood at -$900000.0 in 2022, then rose by 11.78% to -$794000.0 in 2023, then plunged by 48.61% to -$1.2 million in 2024, then tumbled by 99.83% to -$2.4 million in 2025, then increased by 26.72% to -$1.7 million in 2026.
- Per Business Quant, the three latest HBIO Interest & Investment Income figures stand at -$1.7 million (Q1 2026), -$2.4 million (Q4 2025), and -$966000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 12.29 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 5.10 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -62.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 3.91 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -66.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 3.64 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | -1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.73 Mn |
| Dec 31, 2025 | -2.36 Mn |
| Sep 30, 2025 | -966,000.00 |
| Jun 30, 2025 | -791,000.00 |
| Mar 31, 2025 | -933,000.00 |
| Dec 31, 2024 | -1.18 Mn |
| Sep 30, 2024 | -856,000.00 |
| Jun 30, 2024 | -749,000.00 |
| Mar 31, 2024 | -751,000.00 |
| Dec 31, 2023 | -794,000.00 |
| Sep 30, 2023 | -882,000.00 |
| Jun 30, 2023 | -941,000.00 |
| Mar 31, 2023 | -974,000.00 |
| Dec 31, 2022 | -900,000.00 |
| Sep 30, 2022 | -749,000.00 |
| Jun 30, 2022 | -515,000.00 |
| Mar 31, 2022 | -384,000.00 |
| Dec 31, 2021 | -379,000.00 |
| Sep 30, 2021 | -373,000.00 |
| Jun 30, 2021 | -377,000.00 |
| Mar 31, 2021 | -411,000.00 |
| Dec 31, 2020 | -1.09 Mn |
| Sep 30, 2020 | -1.21 Mn |
| Jun 30, 2020 | -1.23 Mn |
| Mar 31, 2020 | -1.30 Mn |
| Dec 31, 2019 | -1.28 Mn |
| Sep 30, 2019 | -1.35 Mn |
| Jun 30, 2019 | -1.38 Mn |
| Mar 31, 2019 | -1.41 Mn |